Cellectar Biosciences, Inc. (CLRB): Operating Cash Flow
-$23.12M
Year ended 2025-12-31
-$19.47M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$23.12M | n/m | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | -$47.58M | n/m | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | -$32.38M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$25.22M | n/m | 2024-10-29, From 2022-01-01 |
| 2021-12-31 | -$22.57M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | -$13.93M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$11.69M | n/m | 2021-03-02, From 2019-01-01 |
| 2018-12-31 | -$11.44M | n/m | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | -$11.02M | n/m | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | -$8.28M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | -$8.21M | n/m | 2017-03-15, From 2015-01-01 |
| 2014-12-31 | -$8.84M | n/m | 2016-10-20, From 2014-01-01 |
| 2013-12-31 | -$9.15M | n/m | 2015-05-20, From 2013-01-01 |
| 2012-12-31 | -$6.59M | n/m | 2013-03-28, From 2012-01-01 |
| 2011-12-31 | -$5.97M | n/m | 2013-03-28, From 2011-01-01 |
| 2010-12-31 | -$3.38M | n/a | 2012-03-09, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | -$23.12M | n/m |
| Cingulate Inc. (CING) | 2025-12-31 | -$17.25M | n/m |
| Synlogic, Inc. (SYBX) | 2025-12-31 | -$4.36M | n/m |
| Biovie Inc. (BIVI) | 2026-06-30 | -$19.02M | n/m |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | -$24.59M | n/m |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | -$12.89M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$8.55M | n/m |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | -$19.21M | n/m |
| CytoDyn Inc. (CYDY) | 2026-05-31 | -$17.25M | n/m |
Compare CLRB, CING, SYBX, BIVI side by side · Screen every company in Pharmaceutical Preparations ↗